{"nct_id":"NCT05232916","title":"Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-08-11","start_date_type":"ACTUAL","primary_completion_date":"2026-12","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GLSI"]}